Medical Technology Industry Reports Insider Sells at 52-Week Lows
1. Vocera Communications (VCRA)
In the past month six members of Vocera’s management team have made seven sells of their company’s stock. These insider sells come as the price of Vocera drops lower into their 52-week low
The six insiders sold a total of 15,950 shares with the most recent sell happening on April 22. These shares traded at an average price of $22.59 for a combined total of $351,416. Since the first of the sells, occurring on April 1, the price has decreased an additional 9.46%.
The company hit a two-year low price of $20.80 this week. According to the GuruFocus analysis the company has no debt. Vocera’s P/B Ratio is also close to a 1-year low of 4.
Vocera Communications provides communications solutions for hospitals. The company not only provides handheld communications devices but also apps for use on the iPhone and Android smart phones. The company’s product is currently used in over 800 hospitals.
The financials of Vocera show that the company has seen an increase in revenue for the past four years, but due to an increase in expense prices and cost of goods the company’s net income and earnings per share show no stable growth.
RS Investment Management holds 281,826 shares of Vocera.
With its shares down 0.19%, Vocera trades at $20.92.
2. Edwards Lifesciences Corporation (EW)
Edwards Lifesciences reported the two most interesting insider sells this month. Both Chairman and CEO Michael Mussallem and Corporate VP of Japan and Intercontinental Huimin Wang made sells as the price was inching closer to its 52-week low price of $81.40.
On April 5, Wang sold 4,850 shares at $81.74 per share. This brought in $396,439 for Wang.
On April 10, Mussallem sold 35,000 of his shares at a price of $83.37. This raked in $2,917,950 for Mussallem.
What is most interesting is that since these sells occurred, the price of the company has dropped over 20% and over $20 per share.
The shares of Edwards Lifesciences dropped more than 20% on Wednesday, April 24, as the company released its first quarter results. The drop came after the company cut its forecast for sales of its Sapien heart valve.
“Sales of the Sapien valve rose 40 percent to $169.7 million in the first quarter, but Edwards said it now expects sales to grow 25 to 30 percent for the full year. That implies a total of $670 million to $7750 million — below its previous forecast of 30 to 45 percent growth, or $710 million to $790 million in Sapien sales,” the company said in a statement.
Edwards Lifesciences is a medical supply company that provides products and technologies that are designed to treat advanced cardiovascular diseases.
The financials of the company show consistent revenue and earnings growth for the past ten years.
EW data by GuruFocus.com
With the approximately $20 drop in share prices, Edwards now trades in the $65 range. This is the lowest the price has been since November 2011.
Seven Gurus hold a stake in EW. To see the full list of these gurus and the shares they hold, click here.
With its shares up 1.78%, Edwards Financial trades at $65.75.
3. TIBCO Software (TIBX)
Executive VP and CFO Sydney Carey made two significant sells as the price of TIBCO Software continues to propel downward in its 52-week low.
Care sold a total of 40,000 shares at an average price of $19.89. Carey brought in $789,100 with these sells.
These sells came as the company’s price is nearing a 52-week low of $18.41.
TIBCO Software is an independent provider of infrastructure software. The company offers products in three major groups: service-oriented architecture, business optimization and business process management.
The financials of the company have shown consistent growth in its revenue and earnings. TIBCO’s P/B Ratio is close to a two-year low of 3.26 and its P/S eatio is close to a three-year low of 2.64.
TIBX data by GuruFocus.com
There are currently eight gurus that hold a stake in TIBCO. To see these gurus and the shares they hold, click here.
With its shares up 1.54%, TIBCO trades at $19.07.
To view all of the companies reporting insider trades at 52-week lows, click here.